ClinicalTrials.Veeva

Menu

Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population

Y

Yan Yan

Status

Enrolling

Conditions

Impaired Glucose Tolerance
Prediabetic State
Obese
Overweight

Treatments

Other: Acupuncture
Other: Sham Acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT05347030
2021-021-KY-01

Details and patient eligibility

About

This is a prospective, multicenter, parallel-group, participants- and assessors-blinded randomized trial aiming to evaluate the effectiveness and safety of acupuncture in improving glucose metabolism for overweight/obese Participants with IGT, in comparison with sham acupuncture.

Full description

The trial will be conducted at three hospitals in China. 196 eligible subjects will be randomly assigned (1:1) to the acupuncture or sham acupuncture group to receive either 30-session acupuncture/sham acupuncture treatment over 12 weeks based on lifestyle intervention and 24-week follow-up. The primary outcome is the change in the value of 2-hour blood glucose (2hPG) from baseline at the end of the 12-week treatment. Additionally, compliance, blinding, and safety will also be assessed. All statistical tests will be performed using a two-sided test, a p-value of less than 0.05 is considered significant.

Enrollment

196 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. those who meet the diagnostic criteria of overweight/obesity and IGT:

    ①IGT: fasting blood glucose (PG) is lower than 7.0mmol/L, and 2-hour blood glucose (2hPG) after oral 75g glucose tolerance test (OGTT) is between 7.8~11.1mmol/L.

    ②overweight: 24.0 < BMI ≤ 27.9, obesity: BMI ≥ 28.0, or BMI ≤24.0 but Waist Circumference ≥85 cm (male) /≥80 cm(female).

  2. 18-60 years old;

  3. those who can appropriately describe their wishes, voluntarily fill in the informed consent form and agree to participate in clinical trials.

Exclusion criteria

  1. obesity secondary to heredity, drugs, and diseases;
  2. those who have received weight-loss treatment including acupuncture and drugs in the past 3 months;
  3. those who have taken drugs that have known effects on body weight or appetite in the past 3 months, such as corticosteroids, antidepressants, non-selective antihistamines in vivo, nicotine substitutes, etc;
  4. IGT is caused by abnormal thyroid function, endocrine tumors, extensive liver damage;
  5. abnormal glucose tolerance caused by thiazide diuretics, β-blockers, nicotinic acid drugs, quinolones, calcineurin inhibitors, interferon-alpha, etc;
  6. received antidiabetic medicines in the past 3 months;
  7. participants with serious primary diseases such as heart, lung, brain, liver, or hematopoietic system diseases, progressive malignant tumor, or other serious consumptive diseases;
  8. Participants with cognitive impairment and severe mental illness;
  9. participants with blood coagulation dysfunction, and scare of needles;
  10. pregnant, breastfeeding, or planning to conceive within 37 weeks.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

196 participants in 2 patient groups

Acupuncture Group
Experimental group
Description:
The acupuncture points are: EX-B3, BL18, BL20, BL21, GV20, GV29, LI11, CV12, CV10, ST25, CV6, CV4, ST40, SP6. After piercing 15-35mm into the skin, the needles will be gently rotated and lifted three times to achieve a sense of sourness, distention, and heaviness (de qi). For EX-B3, BL18, BL20, and BL21, withdrawn afterward immediately. For GV20, GV29, LI11, CV12, CV10, ST25, CV6, CV4, ST40 and SP6, The needles will be maintained for 30 minutes.
Treatment:
Other: Acupuncture
Sham Acupuncture Group
Sham Comparator group
Description:
sham acupoints are located at a horizontal distance of 20 mm to those points used in the acupuncture group, and no manipulation was carried out after piercing the skin for 1-2mm to avoid de-qi sensation. For sham EX-B3, BL18, BL20, and BL21, withdraw immediately after piercing. For sham GV20, GV29, LI11, CV12, CV10, ST25, CV6, CV4, ST40 and SP6, The needles will be maintained for 30 minutes after puncture.
Treatment:
Other: Sham Acupuncture

Trial contacts and locations

1

Loading...

Central trial contact

Yan Yan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems